Skip to content
Cyclodextrin News

Cyclodextrin News

A forum for researchers, students and applicants in the field of cyclodextrin technology

  • Home
  • Pharma applications
  • Non-pharma applications
  • CD derivatives
  • Events
  • E-ducation

Tag: neuromuscular blocker

December 2, 2020 Pharma applications

Pillar[n]MaxQ: A New High Affinity Host Family for Sequestration in Water

Lyle Isaacs and his research team from the University of Maryland have further advanced the structure of the pillararenes to

Continue reading

Recent Posts

  • Rafael Holdings Announced Submission of New Drug Application to FDA for Trappsol®Cyclo™ (remibetadex) for the Treatment of Niemann-Pick Disease Type C
  • New book on cyclodextrin glucanotransferase
  • Cyclodextrin-Branched Polymer Releasing Nitric Oxide with Fluorescent Self-Reporting and Its Combination with Doxorubicin
  • Innovative Titanium Coatings for Enhanced Dental Implants
  • Bio-inks for skin regeneration: phase-adaptive design, multifunctional platforms, and 4D bioprinting frontiers

Tags

alpha-CD atherosclerosis Cancer therapy Captisol Cholesterol Clinical trial conference Covid-19 cyclodextrin polymer Dexolve drug delivery drug delivery systems electrospinning FDA Food gamma-CD Gilead HPBCD hydrogel methyl BCD Nanoparticles Niemann Pick Disease RAMEB remdesivir review SBECD Special issue Sugammadex Synthesis

Follow Us

  • LinkedIn
  • X
  • Facebook

Categories

  • Agriculture (28)
  • Analysis (75)
  • CD as API (360)
  • CD derivatives (442)
  • Cosmetics and toilettry (55)
  • Diagnosis (15)
  • Drug delivery (827)
  • E-ducation (64)
  • Environmental (144)
  • Events (242)
  • Food (239)
  • Gene delivery (22)
  • Household products (6)
  • In Hungarian (4)
  • Life sciences (46)
  • Non-pharma applications (428)
  • Other industrial use (114)
  • Pharma applications (1,236)
  • Supramolecular systems (45)
  • Uncategorized (174)

Top Posts

  • Rafael Holdings Announced Submission of New Drug Application to FDA for Trappsol®Cyclo™ (remibetadex) for the Treatment of Niemann-Pick Disease Type C
  • Mallinckrodt gave up further development of adrabetadex (VTS-270; HPBCD)
  • Health Canada’s Proposal to Enable the Use of alpha-Cyclodextrin as an Emulsifying, Stabilizing or Thickening Agent in Various Foods
  • HPαCD Therapy: A Breakthrough for Krabbe Disease Treatment
  • A cyclodextrin polymer that could change the future of batteries
  • Practical Considerations about the Cyclodextrin Solubilities – A Quickstart Guide for Newbies
  • New book on cyclodextrin glucanotransferase
  • Prof. Kohzo Ito at ICS 20
  • The monograph of SBECD is official in the European Pharmacopeia
  • 16th Central European Symposium on Pharmaceutical Technology (CESPT 2027)

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 4,470 other subscribers
Loading Comments...